The anti-Müllerian hormone (AMH) is a glycoprotein that plays an important role in prenatal sex differentiation. It is used as a biomarker in polycystic ovary syndrome (PCOS) diagnostics, as well as for estimating an individual's ovarian reserve and the ovarian response to hormonal stimulation during in vitro fertilization (IVF). The aim of this study was to test the stability of AMH during various preanalytical conditions that are in accordance with the ISBER (International Society for Biological and Environmental Repositories) protocol. Plasma and serum samples were taken from each of the 26 participants. The samples were then processed according to the ISBER protocol. AMH levels were measured in all the samples simultaneously using the chemiluminescent kit ACCESS AMH in a UniCel® DxI 800 Immunoassay System (Beckman Coulter, Brea, CA, USA). The study proved that AMH retains a relatively high degree of stability during repeated freezing and thawing in serum. AMH was shown to be less stable in plasma samples. Room temperature proved to be the least suitable condition for the storage of samples before performing the biomarker analysis. During the testing of storage stability at 5-7 °C, the values decreased over time for all the plasma samples but remained stable in the serum samples. We proved that AMH is highly stable under various stress conditions. The anti-Müllerian hormone retained the greatest stability in the serum samples.

Department of Chemistry and Biochemistry Faculty of Medicine in Pilsen Charles University 32300 Pilsen Czech Republic

Department of Immunochemistry University Hospital and Faculty of Medicine in Pilsen Charles University 32300 Pilsen Czech Republic

Department of Otorhinolaryngology University Hospital and Faculty of Medicine in Pilsen Charles University 30955 Pilsen Czech Republic

Department of Pharmacology and Toxicology Faculty of Medicine in Pilsen Charles University 32300 Pilsen Czech Republic

See more in PubMed

Silva M.S.B., Giacobini P. New insights into anti-Müllerian hormone role in the hypothalamic–pituitary–gonadal axis and neuroendocrine development. Cell. Mol. Life Sci. 2021;78:1–16. doi: 10.1007/s00018-020-03576-x. PubMed DOI PMC

Broekmans F.J., Visser J.A., Laven J.S.E., Broer S.L., Themmen A.P.N., Fauser B.C. Anti-Müllerian hormone and ovarian dysfunction. Trends. Endocrinol. Metab. 2008;19:340–347. doi: 10.1016/j.tem.2008.08.002. PubMed DOI

La Marca A., Volpe A. Anti-Müllerian hormone (AMH) in female reproduction: Is measurement of circulating AMH a useful tool? Clin. Endocrinol. 2006;64:603–610. doi: 10.1111/j.1365-2265.2006.02533.x. PubMed DOI

Rey R., Lucas-Croiser C., Lasala C., Bedecarras P. AMH/MIS: What we know already about the gene, the protein and its regulation. Mol. Cell. Endocrinol. 2003;211:21–31. doi: 10.1016/j.mce.2003.09.007. PubMed DOI

La Marca A., Broekmans F.J., Volpe A., Fauser B.C., Macklon N.S. Anti-Müllerian hormone (AMH): What do we still need to know? Hum. Reprod. 2009;24:2264–2275. doi: 10.1093/humrep/dep210. PubMed DOI

Lee M.M., Misra M., Donahoe P.K., MacLaughlin D.T. MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol. Cell. Endocrinol. 2003;211:91–98. doi: 10.1016/j.mce.2003.09.014. PubMed DOI

Josso N., Picard J.Y., Rey R., di Clemente N. Testicular anti-Müllerian hormone: History, genetics, regulation and clinical applications. Pediatr. Endocrinol. Rev. PER. 2006;3:347–358. PubMed

Rudnicka E., Kunicki M., Calik-Ksepka A., Suchta K., Duszewska A., Smolarczyk R. Anti-müllerian hormone in pathogenesis, diagnostic and treatment of PCOS. Int. J. Mol. Sci. 2021;22:12507. doi: 10.3390/ijms222212507. PubMed DOI PMC

Erel C.T., Ozcivit I.B. Anti-Müllerian hormone and ovarian aging. Gynecol. Endocrinol. 2021;37:867–868. doi: 10.1080/09513590.2021.1977276. PubMed DOI

Anderson R.A., Su H.I. The clinical value and interpretation of anti-müllerian hormone in women with cancer. Front. Endocrinol. 2020;11:574263. doi: 10.3389/fendo.2020.574263. PubMed DOI PMC

Brady P.C., Ginsburg E.S. Antimüllerian hormone: Don’t put all the eggs in one basket. Fertil. Steril. 2018;110:412. doi: 10.1016/j.fertnstert.2018.04.001. PubMed DOI

Barad D.H., Kim A., Weghofer A., Gleicher N. Does hormonal contraception prior to in vitro fertilization (IVF) negatively affect oocyte yields?—A pilot study. Reprod. Biol. Endocrinol. 2013;11:28. doi: 10.1186/1477-7827-11-28. PubMed DOI PMC

Magnusson Å., Oleröd G., Thurin-Kjellberg A., Bergh C. The correlation between AMH assays differs depending on actual AMH levels. Hum. Reprod. Open. 2017;2017:hox026. doi: 10.1093/hropen/hox026. PubMed DOI PMC

Moolhuijsen L.M.E., Visser J.A. Anti-Müllerian hormone and ovarian reserve: Update on assessing ovarian function. J. Clin. Endocrinol. Metab. 2020;105:3361–3373. doi: 10.1210/clinem/dgaa513. PubMed DOI PMC

Teede H., Misso M., Tassone E.C., Dewailly D., Ng E.H., Azziz R., Norman R.J., Andersen M., Franks S., Hoeger K., et al. Anti-Müllerian hormone in PCOS: A review informing international guidelines. Trends Endocrinol. Metab. 2019;30:467–478. doi: 10.1016/j.tem.2019.04.006. PubMed DOI

De Loos A.D., Hund M., Buck K., Meun C., Sillman J., Laven J.S.E. Antimüllerian hormone to determine polycystic ovarian morphology. Fert. Steril. 2021;116:1149–1157. doi: 10.1016/j.fertnstert.2021.05.094. PubMed DOI

Bedenk J., Vrtačnik-Bokal E., Virant-Klun I. The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility. J. Assist. Reprod. Gen. 2019;37:89–100. doi: 10.1007/s10815-019-01622-7. PubMed DOI PMC

Buratini J., Dellaqua T.T., Dal Canto M., La Marca A., Carone D., Renzini M.M., Webb R. The putative roles of FSH and AMH in the regulation of oocyte developmental competence: From fertility prognosis to mechanisms underlying age-related subfertility. Hum. Reprod. Update. 2022;28:232–254. doi: 10.1093/humupd/dmab044. PubMed DOI

Nelson S.M., Larsson P., Mannaerts B.M.J.L., Andersen A.N., Fauser B.C.J.M. Anti-Müllerian hormone variability and its implications for the number of oocytes retrieved following individualized dosing with follitropin delta. Clin. Endocrinol. 2019;90:719–726. doi: 10.1111/cen.13956. PubMed DOI

Grinspon R.P., Gottlieb S., Bedecarrás P., Rey R.A. Anti-Müllerian hormone and testicular function in prepubertal boys with cryptorchidism. Front. Endocrinol. 2018;9:182. doi: 10.3389/fendo.2018.00182. PubMed DOI PMC

Kanakatti Shankar R., Dowlut-McElroy T., Dauber A., Gomez-Lobo V. Clinical utility of anti-müllerian hormone in pediatrics. J. Clin. Endocrinol. Metab. 2022;107:309–323. doi: 10.1210/clinem/dgab687. PubMed DOI PMC

Betsou F., Gunter E., Clements J., DeSouza Y., Goddard K.A., Guadagni F., Yan W., Skubitz A., Somiari S., Yeadon T., et al. Identification of evidence-based biospecimen quality-control tools: A report of the International Society for Biological and Environmental Repositories (ISBER) biospecimen science working group. J. Mol. Diagn. 2013;15:3–16. doi: 10.1016/j.jmoldx.2012.06.008. PubMed DOI PMC

ISBER. [(accessed on 25 April 2022)]. Available online: https://cdn.ymaws.com/www.isber.org/resource/resmgr/documents/STABCALC-SOP.pdf.

Groome N.P., Cranfield M., Themmen A.P.N., Savjani G.V., Mehta K. Immunological Assay and Antibodies for Anti-Mullerian Hormone. 7,897,350 B2. U.S. Patent. 2011 March 1;

Demirdjian G., Bord S., Lejeune C., Masica R., Rivière D., Nicouleau L., Denizot P., Marquet P.Y. Performance characteristics of the Access AMH assay for the quantitative determination of anti-Müllerian hormone (AMH) levels on the Access* family of automated immunoassay systems. Clin. Biochem. 2016;49:1267–1273. doi: 10.1016/j.clinbiochem.2016.08.005. PubMed DOI

Jopling H., Yates A., Burgoyne N., Hayden K., Chaloner C., Tetlow L. Paediatric Anti-Müllerian Hormone measurement: Male and female reference intervals established using the automated Beckman Coulter Access AMH assay. Endocrinol. Diab. Metab. 2018;18:4. doi: 10.1002/edm2.21. PubMed DOI PMC

Narayanan S. The preanalytic phase. An important component of laboratory medicine. Am. J. Clin. Pathol. 2000;113:429–452. doi: 10.1309/C0NM-Q7R0-LL2E-B3UY. PubMed DOI

Marko-Varga G., Végvári Á., Welinder C., Lindberg H., Rezeli M., Edula G., Svensson K.J., Belting M., Laurell T., Fehniger T.E. Standardization and utilization of biobank resources in clinical protein science with examples of emerging applications. J. Proteom. Res. 2012;11:5124–5134. doi: 10.1021/pr300185k. PubMed DOI

Campbell L.D., Astrin J.J., DeSouza Y., Giri J., Patel A.A., Rawley-Payne M., Rush A., Sieffert N. The 2018 revision of the isber best practices: Summary of changes and the editorial team’s development process. Biopreserv. Biobank. 2018;16:3–6. doi: 10.1089/bio.2018.0001. PubMed DOI PMC

Pankhurst M.W., McLennan I.S. Human blood contains both the uncleaved precursor of anti-Müllerian hormone and a complex of the NH2- and COOH-terminal peptides. Am. J. Physiol. Endocrinol. Metab. 2013;305:1241–1247. doi: 10.1152/ajpendo.00395.2013. PubMed DOI

Wissing M.L., Mikkelsen A.L., Kumar A., Kalra B., Pors S.E., Flachs E.M., Andersen C.Y. Associations of different molecular forms of antimüllerian hormone and biomarkers of polycystic ovary syndrome and normal women. Fertil. Steril. 2019;112:149–155. doi: 10.1016/j.fertnstert.2019.03.002. PubMed DOI

La Marca A., Grisendi V., Griesinger G. How much does AMH really vary in normal women? Int. J. Endocrinol. 2013;2013:959487. doi: 10.1155/2013/959487. PubMed DOI PMC

Melado L., Lawrenz B., Sibal J., Abu E., Coughlan C., Navarro A.T., Fatemi H.M. Anti-müllerian hormone during natural cycle presents significant intra and intercycle variations when measured with fully automated assay. Front. Endocrinol. 2018;9:686. doi: 10.3389/fendo.2018.00686. PubMed DOI PMC

Gorkem U., Kucukler F.K., Togrul C., Gungor T. Anti-Müllerian hormone exhibits a great variation in infertile women with different ovarian reserve patterns. Aust. N. Z. J. Obstet. Gynaecol. 2017;57:464–468. doi: 10.1111/ajo.12625. PubMed DOI

Overbeek A., Broekmans F.J., Hehenkamp W.J., Wijdeveld M.E., van Disseldorp J., van Dulmen-den Broeder E., Lambalk C.B. Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: A re-analysis. Reprod. Biomed. Online. 2012;24:664–669. doi: 10.1016/j.rbmo.2012.02.023. PubMed DOI

Landersoe S.K., Larsen E.C., Forman J.L., Petersen K.B., Kroman M.S., Fredriksen H., Juul A., Nøhr B., Løssl K., Nielsen H.S., et al. Ovarian reserve markers and endocrine profile during oral contraception: Is there a link between the degree of ovarian suppression and AMH? Gynecol. Endocrinol. 2020;36:1090–1095. doi: 10.1080/09513590.2020.1756250. PubMed DOI

Bernardi L.A., Weiss M.S., Waldo A., Harmon Q., Carnethon M.R., Baird D.D., Wise L.A., Marsh E.E. Duration, recency, and type of hormonal contraceptive use and antimullerian hormone levels. Fertil. Steril. 2021;116:208–217. doi: 10.1016/j.fertnstert.2021.02.007. PubMed DOI PMC

Hariton E., Shirazi T.N., Douglas N.C., Hershlag A., Briggs S.F. Anti-Müllerian hormone levels among contraceptive users: Evidence from a cross-sectional cohort of 27,125 individuals. Am. J. Obstet. Gynecol. 2021;225:e1–e515. doi: 10.1016/j.ajog.2021.06.052. PubMed DOI

Lee J.E., Kim S.Y., Shin S.Y. Effect of repeated freezing and thawing on biomarker stability in plasma and serum samples. Osong Public Health Res. Perspect. 2015;6:357–362. doi: 10.1016/j.phrp.2015.11.005. PubMed DOI PMC

Pawlik-Sobecka L., Solkiewicz K., Kokot I., Kiraga A., Placzkowska S., Schlichtinger A.M., Kratz E.M. The influence of serum sample storage conditions on selected laboratory parameters related to oxidative stress: A preliminary study. Diagnostics. 2020;10:51. doi: 10.3390/diagnostics10010051. PubMed DOI PMC

Fleming R., Fairbairn C., Blaney C., Lucas D., Gaudoin M. Stability of AMH measurement in blood and avoidance of proteolytic changes. Reprod. Biomed. Online. 2013;26:130–132. doi: 10.1016/j.rbmo.2012.11.005. PubMed DOI

Hedayati M., Razavi S.A., Broomand S., Kia S.K. The impact of pre-analytical variations on biochemical analytes stability: A systematic review. J. Clin. Lab. Anal. 2020;34:e23551. doi: 10.1002/jcla.23551. PubMed DOI PMC

Zaninotto M., Tasinato A., Padoan A., Vecchiato G., Pinato A., Sciacovelli L., Plebani M. An integrated system for monitoring the quality of sample transportation. Clin. Biochem. 2012;45:688–690. doi: 10.1016/j.clinbiochem.2012.02.013. PubMed DOI

Kumar A., Kalra B., Patel A., McDavid L., Roudebush W.E. Development of a second generation anti-Müllerian hormone (AMH) ELISA. J. Immunol. Methods. 2010;362:51–59. doi: 10.1016/j.jim.2010.08.011. PubMed DOI

Alper M.M., Fauser B.C. Ovarian stimulation protocols for IVF: Is more better than less? Reprod. Biomed. Online. 2017;34:345–353. doi: 10.1016/j.rbmo.2017.01.010. PubMed DOI

Kasaven L.S., Goumenou A., Adegoke K. Multiorgan failure associated with severe ovarian hyperstimulation syndrome due to inadequate protocol optimization: A rare but avoidable complication. BJM Case Rep. 2018;2018:bcr2017223418. doi: 10.1136/bcr-2017-223418. PubMed DOI PMC